Liquid biopsy for detecting epidermal growth factor receptor mutation among patients with non-small cell lung cancer treated with afatinib: a multicenter prospective study

Liquid biopsy for detecting epidermal growth factor receptor mutation among patients with non-small cell lung cancer treated with afatinib: a multicenter prospective study

Abstract Background This study aimed to determine the effectiveness of liquid biopsy in detecting epidermal growth factor receptor (EGFR) mutations at diagnosis, disease progression, and intermediate stages. Methods This prospective, multicenter, observational study included 30 patients with non-sma...

Full description

Bibliographic Details
Main Authors:	Hiroaki Fujii, Hideyuki Nagakura, Nobuaki Kobayashi, Sousuke Kubo, Katsushi Tanaka, Keisuke Watanabe, Nobuyuki Horita, Yu Hara, Masanori Nishikawa, Kenji Miura, Harumi Koizumi, Yu Ito, Motofumi Tsubakihara, Naoki Miyazawa, Makoto Kudo, Masaharu Shinkai, Takeshi Kaneko
Format:	Article
Language:	English
Published:	BMC 2022-10-01
Series:	BMC Cancer
Subjects:	Cell-free deoxyribonucleic acid Epidermal growth factor receptor Liquid biopsy Non-small cell lung cancer Second-generation epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors
Online Access:	https://doi.org/10.1186/s12885-022-10135-z

Similar Items

Strategies for monitoring and combating resistance to combination kinase inhibitors for cancer therapy
by: Leanne G. Ahronian, et al.
Published: (2017-04-01)

Afatinib and Temozolomide combination inhibits tumorigenesis by targeting EGFRvIII-cMet signaling in glioblastoma cells
by: Raghupathy Vengoji, et al.
Published: (2019-06-01)

Potential Role of EGF and EGFR in Tongue Coating Formation
by: Yi-Shuang Tang, et al.
Published: (2016-12-01)

Durable response to afatinib rechallenge in a long‐term survivor of non‐small cell lung cancer harboring EGFR L858R and L747V mutations
by: Mio Kanbe, et al.
Published: (2022-11-01)

Prospective exosome‐focused translational research for afatinib study of non‐small cell lung cancer patients expressing EGFR (EXTRA study)
by: Yusuke Okuma, et al.
Published: (2019-02-01)

Correlation between Grade in Transitional Cell Carcinoma (TCC) and Expression of Epidermal Growth Factor Receptor (EGFR)
by: MR Jallali Nadoushan, et al.
Published: (2007-08-01)

The spatial organization of the epidermal growth factor receptor on the surface of colorectal carcinoma cells
by: Fournier, C
Published: (2015)

Retrospective analysis to assess the feasibility of escalated dose of nimotuzumab in patients with locally advanced head and neck cancer
by: Nagraj Gururaj Huilgol, et al.
Published: (2017-01-01)

Serum Epidermal Growth Factor in Cancer Breast
by: El-Attar HA, et al.
Published: (2007-06-01)

Molecular Docking Optimization in the Context of Multi-Drug Resistant and Sensitive EGFR Mutants
by: María Jesús García-Godoy, et al.
Published: (2016-11-01)

Epidermal growth factor receptor: Role in human cancer
by: Prashanth Rajaram, et al.
Published: (2017-01-01)

Progress and prospect of epidermal growth factor receptor tyrosine kinase inhibitor in treatment of non-small cell lung cancer
by: JIANG Hanshui, et al.
Published: (2022-12-01)

Baseline anemia predicts a poor prognosis in patients with non-small cell lung cancer with epidermal growth factor receptor mutations: a retrospective study
by: Jingwen Wei, et al.
Published: (2022-10-01)

Clinical case of long-term use of osimertinib in the treatment of EGFR mutation-positive lung adenocarcinoma
by: Svetlana V. Odintsova, et al.
Published: (2020-07-01)

Afatinib-induced bronchiolitis obliterans
by: Tadayuki Nakashima, et al.
Published: (2023-06-01)

Construction of an immunotoxin by linking a monoclonal antibody against the human epidermal growth factor receptor and a hemolytic toxin
by: ANA D AVILA, et al.
Published: (2007-01-01)

Afatinib for the Treatment of NSCLC with Uncommon EGFR Mutations: A Narrative Review
by: Yingying Jiang, et al.
Published: (2023-05-01)

Ceramide Is Involved in Temozolomide Resistance in Human Glioblastoma U87MG Overexpressing EGFR
by: Rosaria Bassi, et al.
Published: (2023-10-01)

Prognostic role of epidermal growth factor receptors’ expression in patients with i-ii stage of non-small cell lung cancer
by: A.P. Kolesnik, et al.
Published: (2013-08-01)

High level of EGF-R expression in carcinomatous skin invasion: Does it reflect the tissue characteristics of the breast carcinoma aggressiveness?
by: Nešković-Konstantinović Zora B., et al.
Published: (2002-01-01)

Effect of epidermal growth factor on proliferation and migration of retinal pigment epithelial cells through EGFR/AKT signaling pathway
by: Xiao-Dong Chen, et al.
Published: (2018-02-01)

A Novel Oncogenic Driver in a Lung Adenocarcinoma Patient Harboring an EGFR-KDD and Response to Afatinib
by: Dong Chen, et al.
Published: (2020-06-01)

The difference between dacomitinib and afatinib in effectiveness and safety in first-line treatment of patients with advanced EGFR-mutant non-small cell lung cancer: a real-world observational study
by: Wen-Chien Cheng, et al.
Published: (2024-02-01)

Local Consolidative Therapy May Have Prominent Clinical Efficacy in Patients with <i>EGFR</i>-Mutant Advanced Lung Adenocarcinoma Treated with First-Line Afatinib
by: Ming-Ju Tsai, et al.
Published: (2023-03-01)

Improving the anticancer effect of afatinib and microRNA by using lipid polymeric nanoparticles conjugated with dual pH-responsive and targeting peptides
by: Shu-Ting Hong, et al.
Published: (2019-08-01)

The effect of tyrphostins AG494 and AG1478 on the autocrine growth regulation of A549 and DU145 cells
by: Agnieszka Bojko, et al.
Published: (2012-07-01)

Is oligoprogression a potentially curable disease in epidermal growth factor receptor mutant lung adenocarcinoma?
by: Sviatoslav Chekhun, et al.
Published: (2023-12-01)

Molecular Recognition and Quantification of HER-3, HER-4 and HRG-α in Whole Blood and Tissue Samples Using Stochastic Sensors
by: Raluca-Ioana Stefan-van Staden, et al.
Published: (2022-10-01)

Spotlight on afatinib and its potential in the treatment of squamous cell lung cancer: the evidence so far
by: Xu Y, et al.
Published: (2016-05-01)

EGFR-mutated, metastatic pulmonary pleomorphic carcinoma successfully treated with afatinib
by: Akira Kawamura, et al.
Published: (2022-06-01)

Impact of epidermal growth factor receptor gene RS1468727 polymorphism on survival of the patients with oral squamous cell carcinoma
by: Bačulov Katarina, et al.
Published: (2023-01-01)

Epidermal growth factor receptor as an early diagnostic marker of oral squamous cell carcinoma: Marking the line between severe dysplasia and oral squamous cell carcinoma
by: Sankeerti Mala
Published: (2019-01-01)

Role of EGFR Gene Polymorphisms in Oral Squamous Cell Carcinoma patients of Southeast of Iran: A Case-Control Study
by: Shirin Saravani, et al.
Published: (2020-06-01)

Adverse Events of Afatinib as First-line Treatment for Five Cases of Advanced Lung Adenocarcinoma and Review of Literature
by: Hong TAO, et al.
Published: (2014-04-01)

Association Study of Polymorphisms of Epidermal Growth Factor and Epidermal Growth Factor Receptor With Benign Prostatic Hyperplasia in a Korean Population
by: Su Kang Kim, et al.
Published: (2016-12-01)

Low-dose arsenite causes overexpression of EGF, TGFα, and HSP90 through Trx1-TXNIP-NLRP3 axis mediated signaling pathways in the human bladder epithelial cells
by: Peiyu Jin, et al.
Published: (2022-12-01)

Epidermal growth factor promotes intestinal secretory cell differentiation in weaning piglets via Wnt/β-catenin signalling
by: L.X. Wang, et al.
Published: (2020-01-01)

Clinicopathological Parameters and Immunohistochemical Expression of EGFR in Colorectal Carcinoma: A Cross-sectional Study
by: Bindhuja Joseph
Published: (2023-10-01)

PRIDE syndrome associated with panitumumab treatment – case report and literature review
by: Magalena Pałdyna, et al.
Published: (2023-05-01)

Prognosis and Survival Study in Patients with Glioblastoma Multiform and Its Relationship with EGFR Expression
by: Zeinab Amirpour, et al.
Published: (2020-07-01)